10x Genomics (TXG) Capital Expenditures (QoQ) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn |
| 10 | Teladoc Health | 1.42 Bn | 672.39 Mn | 562.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -93.36% |
| Dec 31, 2025 | 158.66% |
| Sep 30, 2025 | -56.46% |
| Jun 30, 2025 | -16.64% |
| Mar 31, 2025 | -83.45% |
| Dec 31, 2024 | 336.64% |
| Sep 30, 2024 | -224.30% |
| Jun 30, 2024 | 104.79% |
| Mar 31, 2024 | 347.88% |
| Dec 31, 2023 | 101.57% |
| Sep 30, 2023 | -3,487.65% |
| Jun 30, 2023 | -102.46% |
| Mar 31, 2023 | -70.04% |
| Dec 31, 2022 | 492.75% |
| Sep 30, 2022 | -164.63% |
| Jun 30, 2022 | 168.47% |
| Mar 31, 2022 | 126.50% |
| Dec 31, 2021 | -185.70% |
| Sep 30, 2021 | 1,307.32% |
| Jun 30, 2021 | 66.90% |
| Mar 31, 2021 | 122.81% |
| Dec 31, 2020 | -2,525.15% |
| Sep 30, 2020 | -95.76% |
| Jun 30, 2020 | 327.14% |
| Mar 31, 2020 | -92.24% |
| Dec 31, 2019 | 1,243.66% |
| Sep 30, 2019 | -149.12% |
| Jun 30, 2019 | 99.66% |
| Mar 31, 2019 | 299.38% |